This panel presentation will address key legal issues for companies and investors as life sciences products move from the laboratory to the marketplace. Join us as we discuss partnering with large pharmaceutical companies, developing a successful patent strategy, understanding patent litigation in the U.S. and Europe and dealing with the FDA. Our panel will offer practical advice on a range of topics pertinent to biotechnology and other healthcare companies.
Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.
Thank you for your interest in WilmerHale.
